NCT03618615 (APIA) is a clinical trial of artericitc surgery in Arteritic Leg Ulcer, sponsored by Central Hospital, Nancy, France.

Who is sponsoring NCT03618615?

NCT03618615 is sponsored by Central Hospital, Nancy, France.

What drugs are being tested in NCT03618615?

Interventions in NCT03618615: artericitc surgery.

What condition does NCT03618615 study?

NCT03618615 studies Arteritic Leg Ulcer.

Is NCT03618615 still recruiting?

NCT03618615 is currently status unknown. Last updated 12 September 2018.

Last reviewed 2018-09-12 · How we verify

NCT03618615: APIA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anatomical Study of the Arteries of the Skin on Amputation Legs

Status unknown Last updated 12 September 2018

What this trial tests

trial testing artericitc surgery in Arteritic Leg Ulcer in 100 participants. Status unknown.

Timeline

30 September 2018

Primary endpoint
30 September 2021

30 September 2021

Quick facts

Lead sponsor	Central Hospital, Nancy, France
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	30 September 2018
Primary completion	30 September 2021
Estimated completion	30 September 2021

Drugs / interventions tested

artericitc surgery — full drug profile →

Conditions studied

Arteritic Leg Ulcer — all drugs for Arteritic Leg Ulcer →

Sponsor

Central Hospital, Nancy, France

Who can join

Adults 18 to 95, any sex, with Arteritic Leg Ulcer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

PRIMARY OBJECTIVE Qualitatively describe the distribution of cutaneous arteries in patients with long-term occlusive arterial disease. SECONDARY OBJECTIVE To compare the distribution of cutaneous arteries observed on the legs of arteritic patients with that observed on non-arteritic legs (from bodies given to science).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03618615 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
Last refreshed: 12 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03618615.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing